Fusion Antibodies plc

Default features description for sign up page.

Updates

Regulatory News

Company Presentations

Webinars

Board Profiles

Company Profile

Home

Fusion Deep Dive

Advisers

Company Information & FAQs

Corporate Governance

Share Price

New investors

Shareholder Information

Raleway

In this Deep Dive, CSO Rick Buick introduces Fusion’s Mammalian Display platform, a key component of the OptiMAL® workflow and an important step forward in antibody discovery.

Rick explains what Mammalian Display is: a system that screens antibodies directly in mammalian cells, giving results that closely reflect how a final therapeutic antibody will behave.

He also explores why this matters for partners, especially those using AI and machine-learning to design antibody libraries. Mammalian Display helps identify higher-quality hits, improve developability, and reduce downstream risk. Recent updates have shown strong early interest in this service as Fusion moves toward the OptiMAL® launch.

Finally, he breaks down how the platform works, from high-throughput cell expression to full-length IgG screening, and how this integrates with Fusion’s broader discovery offering.

Have a question for Richard about Mammalian Display? Submit it below and the team will get back to you.

Deep Dive: Mammalian Display